查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1447016

到 2030 年止咳糖漿市場預測 - 各產品類型、年齡層、配銷通路和地理位置的全球分析

Cough Syrup Market Forecasts to 2030 - Global Analysis By Product Type, Age Group, Distribution Channel and by Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球止咳糖漿市場規模為 631,209 萬美元，預計到 2030 年將達到 876,400 萬美元，預測期內複合CAGR為 4.8%。常用於治療咳嗽症狀的非處方藥是止咳糖漿。止咳糖漿通常含有祛痰劑、止咳劑，偶爾還含有抗組織胺作為活性成分。其主要目標是緩解喉嚨刺激，減少咳嗽的衝動，並促進黏液鬆弛。此外，有些製劑也可能含有退燒藥或止痛藥。止咳糖漿有液體和糖漿等多種劑型，使用簡單。

根據美國肺臟協會的說法，適當的呼吸健康對於整體健康至關重要，定期運動有助於維持強大的肺功能。

市場動態：

驅動因素：

呼吸系統疾病的發生頻率

止咳糖漿的需求很大程度上是由感冒、流感和過敏等呼吸道疾病的持續流行所推動的。由於世界各地有許多人患有這些疾病，因此一直需要止咳產品。此外，止咳糖漿成為尋求快速有效緩解與呼吸道問題相關的煩躁症狀的人的首選。

阻礙因素：

解決根本原因的能力有限

止咳糖漿主要治療呼吸系統疾病的症狀，而不是根本原因。儘管它們可以緩解咳嗽和相關不適，但可能無法治療疾病的根本原因。此外，具有健康意識的消費者對提供全面答案的療法的需求不斷成長，這可能會限制止咳糖漿市場的擴張。

機會：

對兒童止咳糖漿的需求不斷成長

由於人們對兒科健康意識的不斷增強以及對兒童友善藥物的需求不斷成長，因此有機會專門生產兒科止咳糖漿。口味對孩子有吸引力、劑量準確的產品會在市場上流行。此外，透過滿足兒科消費者的特殊需求和偏好，製造商可以從這個市場利基中獲得可觀的利潤。

威脅：

價格侵蝕和學名藥競爭

止咳糖漿市場因學名藥競爭的可能性而受到嚴重課題。當專利到期後學名藥進入市場時，止咳糖漿的價格可能會下降。此外，知名品牌的市場佔有率和獲利能力可能會受到非專利替代品競爭加劇的影響，企業需要製定策略規劃以保持競爭優勢。

Covid-19 影響：

止咳糖漿市場受到了 COVID-19 大流行的多種影響。儘管由於人們越來越關注呼吸系統健康，最初對止咳糖漿等咳嗽和感冒藥物的需求激增，但由於供應鏈、製造和分銷的中斷，該行業面臨困難。封鎖、社會疏離政策和經濟不確定性影響了消費者的購買模式，促使消費者轉向必需品和網路零售商。此外，疫情提高了人們對預防保健和整體健康價值的認知，這可能會影響人們對止咳糖漿的感受和使用方式。

止咳藥/鎮咳藥市場預計將在預測期內成為最大的市場

預計佔有率最大的部分是止咳藥和鎮咳藥。減充血劑，如右美沙芬，可以減輕咳嗽的衝動，進而緩解乾咳、無效咳嗽。這一品類吸引了廣泛的消費者，因為它能有效減輕咳嗽症狀而不使人昏昏欲睡。此外，鎮咳藥經常用於非處方止咳糖漿配方中，因為它們有針對性地治療持續咳嗽，這推動了對它們的需求。

預計在線藥房領域在預測期內的CAGR最高

市場CAGR最高的是在線藥品領域，其中還包括止咳糖漿等非處方藥。由於可近性、便利性和消費者對網上購物的偏好等因素，網路藥局變得越來越受歡迎。此外，客戶可以使用線上平台，在家中舒適地存取多種選擇、比較產品並進行購買。由於社交距離措施，COVID-19 大流行進一步加速了線上藥局的採用。

佔比最大的地區：

預計北美將控制止咳糖漿市場的最大佔有率。該地區的特點是龐大的消費群、完善的醫療基礎設施和高度的醫療保健意識。由於呼吸道疾病較為常見，尤其是在冬季，因此對止咳糖漿有需求。此外，大型製藥公司的存在和消費者對非處方藥的偏好進一步支撐了北美市場。

複合CAGR最高的地區：

止咳糖漿市場預計將以歐洲地區最高的CAGR成長。該地區受益於更容易患呼吸系統疾病的老齡化人口、完善的醫療保健系統和較高的健康意識。此外，冬季感冒和流感季節的傳播傾向增加了對止咳糖漿的穩定需求。由於歐洲傾向於自我藥療和非處方藥，以及藥物研究的進步，因此止咳糖漿市場有望持續成長。

主要進展：

2024年1月，領先的科技公司默克公司宣布與美國公司Inspirna, Inc. 就肌酸轉運通道SLC6A8的一流口服抑製劑歐培那利達成許可協議，後續將針對SLC6A8進行標靶治療。- 化合物。 Ompenaclid 目前正在一項 II 期研究中進行評估，用於 RAS 突變的晚期或轉移性結直腸癌 (mCRC) 的二線治療。

2023 年 9 月，雅培簽署了收購 Bigfoot Biomedical 的最終協議，該公司為糖尿病患者開發智慧胰島素管理系統。自 2017 年以來，兩家公司一直致力於互聯糖尿病解決方案。Bigfoot Unity 由 Bigfoot Biomedical 開發，是一款智慧胰島素管理系統。它具有連接的胰島素筆蓋，使用整合的連續血糖監測 (iCGM)資料和醫療保健提供者的說明。

2023年1月，武田與和記醫療（中國）及其子公司和記醫療簽署獨家許可協議，開發和銷售後者的呋喹替尼。根據交易條款，該公司將獲得呋喹替尼所有適應症以及中國大陸、澳門和香港以外地區的開發和商業化的全球獨家許可。

我們的報告提供了什麼：

  • 區域和國家層面的市場佔有率評估
  • 對新進入者的策略建議
  • 涵蓋2021年、2022年、2023年、2026年及2030年的市場資料
  • 市場趨勢（促進因素、限制因素、機會、威脅、課題、投資機會和建議）
  • 根據市場預測提出關鍵業務部門的策略建議
  • 競爭性景觀美化繪製主要共同趨勢
  • 公司概況，包括詳細的策略、財務狀況和最新發展
  • 反映最新技術進步的供應鏈趨勢

免費客製化產品：

本報告的所有客戶都將有權獲得以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 個）
    • 關鍵參與者的 SWOT 分析（最多 3 個）
  • 區域區隔
    • 根據客戶的興趣對任何主要國家的市場估計、預測和CAGR（註：取決於可行性檢查）
  • 競爭基準化分析
    • 根據產品組合、地理分佈和策略聯盟對主要參與者基準化分析

目錄

第 1 章：執行摘要

第 2 章：前言

  • 抽象的
  • 股東
  • 研究範圍
  • 研究方法論
    • 資料探勘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 研究來源
    • 主要研究來源
    • 二手研究來源
    • 假設

第 3 章：市場趨勢分析

  • 介紹
  • 促進要素
  • 限制
  • 機會
  • 威脅
  • 產品分析
  • 新興市場
  • Covid-19 的影響

第 4 章：波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭競爭

第 5 章：全球止咳糖漿市場：依產品類型

  • 介紹
  • 祛痰藥
  • 止咳藥/鎮咳藥
  • 抗組織胺藥
  • 聯合用藥
  • 其他產品類型

第 6 章：全球止咳糖漿市場：依年齡段

  • 介紹
  • 兒科
  • 成人
  • 青少年

第 7 章：全球止咳糖漿市場：依配銷通路

  • 介紹
  • 零售藥房
  • 醫院藥房
  • 網路藥房

第 8 章：全球止咳糖漿市場：依地理位置

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太地區其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第 9 章：主要進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 擴充
  • 其他關鍵策略

第 10 章：公司概況

  • Takeda Pharmaceutical Company Limited
  • Abbott Laboratories
  • Johnson and Johnson Services, Inc
  • Merck & Co., Inc.
  • Bayer AG
  • Teva Pharmaceuticals Industries Ltd
  • Acella Pharmaceuticals, LLC
  • Sun Pharmaceutical Industries Ltd.
  • Novartis International AG
  • Reckitt Benckiser Group Plc.
  • F. Hoffmann-La Roche Ltd
  • Sanofi
  • AstraZeneca PLC
  • Pfizer Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Cipla Ltd
Product Code: SMRC25277

According to Stratistics MRC, the Global Cough Syrup Market is accounted for $6312.09 million in 2023 and is expected to reach $8764.00 million by 2030 growing at a CAGR of 4.8% during the forecast period. An over-the-counter drug that is frequently used to treat cough symptoms is cough syrup. Cough syrup usually contains expectorants, cough suppressants, and occasionally antihistamines as active ingredients. Its main goals are to ease throat irritation, lessen the urge to cough, and encourage mucus loosening. Moreover, some formulations may also contain fever reducers or pain relievers. Cough syrup comes in a variety of forms, such as liquids and syrups, it is simple to use.

According to the American Lung Association, proper respiratory health is crucial for overall well-being, and regular exercise can contribute to maintaining strong lung function.

Market Dynamics:

Driver:

Frequency of respiratory conditions

Cough syrup demand is largely driven by the ongoing prevalence of respiratory conditions like colds, the flu, and allergies. Since many people throughout the world suffer from these illnesses, there is a constant need for cough relief products. Furthermore, cough syrup becomes the go-to option for people looking for quick and efficient relief from irritable symptoms related to respiratory problems.

Restraint:

Limited ability to address fundamental causes

Cough syrups mainly treat the symptoms of respiratory disorders rather than their underlying causes. Although they alleviate coughing and associated discomfort, they might not treat the underlying cause of the illness. Additionally, the need for therapies that provide comprehensive answers is growing among health-conscious consumers, which could limit the market for cough syrup expansion.

Opportunity:

Growing need for children's cough syrups

There's a chance to create pediatric cough syrups specifically because of the growing awareness of pediatric health and the growing need for kid-friendly medications. Products with flavors that appeal to kids and dosages that are accurate can become popular on the market. Moreover, by catering to the particular needs and preferences of pediatric consumers, manufacturers can make significant profits from this market niche.

Threat:

Price erosion and generic competition

The market for cough syrup is severely challenged by the possibility of generic competition. Cough syrups may see price erosion when generic versions hit the market after a patent expires. Additionally, the market share and profitability of well-known brands may be impacted by increased competition from generic alternatives, necessitating strategic planning on the part of businesses to maintain a competitive advantage.

Covid-19 Impact:

The market for cough syrup has seen a variety of effects from the COVID-19 pandemic. Although there was initially a spike in demand for cough and cold remedies, such as cough syrups, due to the increased focus on respiratory health, the industry faced difficulties due to disruptions in supply chains, manufacturing, and distribution. Lockdowns, social distancing policies, and economic uncertainty affected consumer buying patterns, causing a move toward necessities and internet retailers. Furthermore, the pandemic increased people's awareness of the value of preventive care and general health, which may have an effect on how people feel about and use cough syrups.

The Cough Suppressants/Antitussives segment is expected to be the largest during the forecast period

The segment with the largest share is predicted to be cough suppressants and antitussives. Decongestants, like dextromethorphan, act by lessening the urge to cough, which relieves dry, ineffective coughs. This category appeals to a wide range of consumers because it effectively reduces cough symptoms without making people drowsy. Moreover, antitussives are frequently used in over-the-counter cough syrup formulations due to their targeted approach to treating persistent coughing, which drives demand for them.

The Online Pharmacy segment is expected to have the highest CAGR during the forecast period

The market's highest CAGR has been seen in the online pharmacy sector, which also includes over-the-counter drugs like cough syrups. Online pharmacies are becoming more and more popular due to factors like accessibility, convenience, and consumer preference for online shopping. Additionally, customers can access a multitude of options, compare products, and make purchases from the comfort of their homes with the help of the online platform. Due to social distancing measures, the COVID-19 pandemic has expedited the adoption of online pharmacies even more.

Region with largest share:

It is projected that North America will control the largest share of the cough syrup market. The area is distinguished by a sizable consumer base, a well-established healthcare infrastructure, and high healthcare awareness. There is a demand for cough syrups because respiratory conditions are more common, especially in the winter months. Furthermore, the market in North America is further supported by the presence of large pharmaceutical companies and consumer preferences for over-the-counter medications.

Region with highest CAGR:

The cough syrup market is expected to grow at the highest CAGR in the European region. The area benefits from an aging population that is more susceptible to respiratory disorders, a well-established healthcare system, and high health awareness. Additionally, the wintertime cold and flu season's propensity to spread adds to the steady demand for cough syrups. Europe is positioned for continued growth in the cough syrup market due to its propensity for self-medication and over-the-counter remedies, as well as advances in pharmaceutical research.

Key players in the market

Some of the key players in Cough Syrup market include Takeda Pharmaceutical Company Limited, Abbott Laboratories, Johnson and Johnson Services, Inc, Merck & Co., Inc., Bayer AG, Teva Pharmaceuticals Industries Ltd, Acella Pharmaceuticals, LLC, Sun Pharmaceutical Industries Ltd., Novartis International AG, Reckitt Benckiser Group Plc., F. Hoffmann-La Roche Ltd, Sanofi, AstraZeneca PLC, Pfizer Inc., Eli Lilly and Company, GlaxoSmithKline PLC and Cipla Ltd.

Key Developments:

In January 2024, Merck, a leading science and technology company, has announced a licensing agreement with US-based firm Inspirna, Inc. for ompenaclid, a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds. Ompenaclid is currently being evaluated in a Phase II study for the second-line treatment of RAS-mutated advanced or metastatic colorectal cancer (mCRC).

In September 2023, Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes. Together, the companies have worked on connected diabetes solutions since 2017. Developed by Bigfoot Biomedical, Bigfoot Unity is a smart insulin management system. It features connected insulin pen caps that use integrated continuous glucose monitoring (iCGM) data and healthcare provider instructions.

In January 2023, Takeda has signed an exclusive licence agreement with HUTCHMED (China) and its subsidiary Hutchmed to develop and market the latter's fruquintinib. Under the deal terms, the company will have an exclusive global licence for the development and commercialisation of fruquintinib for all indications and territories outside of mainland China, Macau, and Hong Kong.

Product Types Covered:

  • Expectorants
  • Cough Suppressants/Antitussives
  • Antihistamines
  • Combination Medications
  • Other Product Types

Age Groups Covered:

  • Pediatric
  • Adult
  • Adolescents

Distribution Channels Covered:

  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cough Syrup Market, By Product Type

  • 5.1 Introduction
  • 5.2 Expectorants
  • 5.3 Cough Suppressants/Antitussives
  • 5.4 Antihistamines
  • 5.5 Combination Medications
  • 5.6 Other Product Types

6 Global Cough Syrup Market, By Age Group

  • 6.1 Introduction
  • 6.2 Pediatric
  • 6.3 Adult
  • 6.4 Adolescents

7 Global Cough Syrup Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Pharmacy
  • 7.3 Hospital Pharmacy
  • 7.4 Online Pharmacy

8 Global Cough Syrup Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Takeda Pharmaceutical Company Limited
  • 10.2 Abbott Laboratories
  • 10.3 Johnson and Johnson Services, Inc
  • 10.4 Merck & Co., Inc.
  • 10.5 Bayer AG
  • 10.6 Teva Pharmaceuticals Industries Ltd
  • 10.7 Acella Pharmaceuticals, LLC
  • 10.8 Sun Pharmaceutical Industries Ltd.
  • 10.9 Novartis International AG
  • 10.10 Reckitt Benckiser Group Plc.
  • 10.11 F. Hoffmann-La Roche Ltd
  • 10.12 Sanofi
  • 10.13 AstraZeneca PLC
  • 10.14 Pfizer Inc.
  • 10.15 Eli Lilly and Company
  • 10.16 GlaxoSmithKline PLC
  • 10.17 Cipla Ltd

List of Tables

  • Table 1 Global Cough Syrup Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 4 Global Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 5 Global Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 6 Global Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 7 Global Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 8 Global Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 9 Global Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 10 Global Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 11 Global Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 12 Global Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 13 Global Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 14 Global Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 15 Global Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 16 North America Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 17 North America Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 18 North America Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 19 North America Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 20 North America Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 21 North America Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 22 North America Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 23 North America Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 24 North America Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 25 North America Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 26 North America Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 27 North America Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 28 North America Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 29 North America Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 30 North America Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 31 Europe Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 32 Europe Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 33 Europe Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 34 Europe Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 35 Europe Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 36 Europe Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 37 Europe Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 38 Europe Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 39 Europe Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 40 Europe Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 41 Europe Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 42 Europe Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 43 Europe Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 44 Europe Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 45 Europe Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 46 Asia Pacific Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 47 Asia Pacific Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 48 Asia Pacific Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 49 Asia Pacific Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 50 Asia Pacific Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 51 Asia Pacific Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 52 Asia Pacific Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 53 Asia Pacific Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 54 Asia Pacific Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 55 Asia Pacific Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 56 Asia Pacific Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 57 Asia Pacific Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 58 Asia Pacific Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 59 Asia Pacific Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 60 Asia Pacific Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 61 South America Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 South America Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 63 South America Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 64 South America Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 65 South America Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 66 South America Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 67 South America Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 68 South America Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 69 South America Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 70 South America Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 71 South America Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 72 South America Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 73 South America Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 74 South America Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 75 South America Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)
  • Table 76 Middle East & Africa Cough Syrup Market Outlook, By Country (2021-2030) ($MN)
  • Table 77 Middle East & Africa Cough Syrup Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 78 Middle East & Africa Cough Syrup Market Outlook, By Expectorants (2021-2030) ($MN)
  • Table 79 Middle East & Africa Cough Syrup Market Outlook, By Cough Suppressants/Antitussives (2021-2030) ($MN)
  • Table 80 Middle East & Africa Cough Syrup Market Outlook, By Antihistamines (2021-2030) ($MN)
  • Table 81 Middle East & Africa Cough Syrup Market Outlook, By Combination Medications (2021-2030) ($MN)
  • Table 82 Middle East & Africa Cough Syrup Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 83 Middle East & Africa Cough Syrup Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 84 Middle East & Africa Cough Syrup Market Outlook, By Pediatric (2021-2030) ($MN)
  • Table 85 Middle East & Africa Cough Syrup Market Outlook, By Adult (2021-2030) ($MN)
  • Table 86 Middle East & Africa Cough Syrup Market Outlook, By Adolescents (2021-2030) ($MN)
  • Table 87 Middle East & Africa Cough Syrup Market Outlook, By Distribution Channel (2021-2030) ($MN)
  • Table 88 Middle East & Africa Cough Syrup Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
  • Table 89 Middle East & Africa Cough Syrup Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
  • Table 90 Middle East & Africa Cough Syrup Market Outlook, By Online Pharmacy (2021-2030) ($MN)